“智能”工具助力生物科技领域大单频签
The ‘clever’ tool increasingly getting bigger biotech deals signed
生命科学资讯
生物技术与制药领域的最新动态
挪威银行收购安捷伦科技公司3,347,921股股份 - MarketBeat
3,347,921 Shares in Agilent Technologies, Inc. $A Acquired by Norges Bank - MarketBeat
Imvax公布胶质母细胞瘤治疗二期b阶段数据，计划与FDA会面。
Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA
摩根士丹利将10x Genomics评级从增持下调至平配，目标价从17美元上调至20美元——市场观察者
Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener
安捷伦宣布推出符合21 CFR Part 11法规的xCELLigence RTCA eSight软件 - BioSpace
Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight - BioSpace
随着生物产业增长，全球生命科学第一生产商赛默飞世尔科技（TMO）... - 每日经济新闻
As the bio industry grows, Thermo Fisher Scientific (TMO), the world's No. 1 producer of life scienc.. - 매일경제
Vandria计划B轮融资推进阿尔茨海默病药物进入二期临床试验
Vandria plots Series B raise to advance Alzheimer’s drug into Phase 2
哪些宏观因素可能推动沃特世公司（WAT）股价上涨 - 收益总结报告与每周涨幅领先股提醒 - Newser
What macro factors could drive Waters Corporation (WAZ) stock higher - Earnings Summary Report & Weekly Top Gainers Alerts - Newser
安捷伦科技公司股票是否适合财富增值——2025年7月价格水平与周度高回报机会分析——Newser
Is Agilent Technologies Inc. stock good for wealth creation - July 2025 Levels & Weekly High Return Opportunities - Newser
Thermo Fisher (TMO) 通过浮动与固定利率高级债券筹集21亿欧元 - MSN
Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes - MSN
Lonza集团（普通股）LO31股票将发布积极指引——2025年价格目标与风险控制每日计划——新报
Will Lonza Group AG (Common Stock) (LO31) stock issue positive guidance - 2025 Price Targets & Risk Controlled Daily Plans - Newser
Lonza集团AG（普通股）(LO3A)股票的MACD趋势信号解读——Newser
What MACD trends signal for Lonza Group AG (Common Stock) (LO3A) stock - Newser
众议院通过法案重新授权罕见儿科优先审评券计划；参议院将跟进审议。
House passes bill to reauthorize rare pediatric PRV program; Senate next
FDA采用自主人工智能，推动人工智能在机构内广泛应用。
FDA adopts agentic AI in latest push to infuse artificial intelligence into agency
追踪移动目标
Keeping track of moving targets
摩根士丹利对10X Genomics股票给予“等权重”评级，开始覆盖 - Investing.com
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
摩根士丹利开始覆盖赛默飞世尔股票，给予增持评级 - Investing.com
Morgan Stanley assumes coverage on Thermo Fisher stock with Overweight rating - Investing.com
摩根士丹利将10x Genomics评级从增持下调至平配
10x Genomics downgraded to Equal Weight from Overweight at Morgan Stanley - TipRanks
摩根士丹利对10X Genomics股票给予等权重评级，开始覆盖研究 - Investing.com
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
新ACIP主席声称新冠疫苗导致癌症和流产
New ACIP chair claims Covid-19 vaccines caused cancer, miscarriages